summary
Introduced
01/09/2018
01/09/2018
In Committee
01/09/2018
01/09/2018
Crossed Over
Passed
Dead
01/08/2020
01/08/2020
Introduced Session
2018-2019 Regular Session
Bill Summary
This bill requires hospital service corporations, medical service corporations, health service corporations, commercial insurers and health maintenance organizations to provide benefits for the treatment of Lyme disease determined to be medically necessary by the covered person's physician after making a written evaluation of that person's symptoms, condition and response to treatment. Treatment otherwise eligible for benefits pursuant to this bill could not be denied because such treatment may be characterized as experimental or investigational in nature.
AI Summary
This bill requires hospital service corporations, medical service corporations, health service corporations, commercial insurers, health maintenance organizations, and individual and group health insurance policies to provide benefits for the treatment of Lyme disease that is determined to be medically necessary by the covered person's physician. The bill also stipulates that treatment eligible for benefits cannot be denied on the basis of it being characterized as experimental or investigational in nature. The provisions of the bill apply to all contracts where the insurer or health organization has reserved the right to change the premium.
Committee Categories
Business and Industry
Sponsors (4)
Last Action
Introduced, Referred to Assembly Financial Institutions and Insurance Committee (on 01/09/2018)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| BillText | https://www.njleg.state.nj.us/2018/Bills/A1000/678_I1.HTM |
| Bill | https://www.njleg.state.nj.us/2018/Bills/A1000/678_I1.PDF |
Loading...